Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Publication|Articles|October 28, 2026 Oncology ONCOLOGY Vol 40, Issue 7 Volume 40 Issue 07 Author(s)Daphne P. Edgren, BFA, Pedro Viveiros, MD, Seth M. Pollack, MD A pilot early phase 1 trial (NCT07261657) represents the first clinical effort to activate persisting transferred rare persisting cells by using IL-15 superagonist N-803.
Articles by Pedro Viveiros, MD A pilot early phase 1 trial (NCT07261657) represents the first clinical effort to activate persisting transferred rare persisting cells by using IL-15 superagonist N-803.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.